Scarica l'app Stockscreener
11.90
2.54%
-0.31
Carlsmed Inc Borsa (CARL) Ultime notizie
Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m - 富途牛牛
CARL Initiates Coverage On Needham -- Rating Set to Buy - GuruFocus
Needham initiates Carlsmed stock with buy rating on implant differentiation By Investing.com - Investing.com Nigeria
Needham initiates Carlsmed stock with buy rating on implant differentiation - Investing.com
Needham Initiates Carlsmed(CARL.US) With Buy Rating, Announces Target Price $17 - Moomoo
CARL Forecast — Price Target — Prediction for 2027 - TradingView
Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL) - TradingView
Carlsmed, Inc. Actuals & Estimates (DUS:I82) - TradingView
Price to sales forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
CARL Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Progress ContinuesPre-Announcement Alert - dars.gov.et
I82 Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7) - TradingView
A41CM7 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Price to book forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Price to sales forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed Inc. (CARL) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Form 4 Carlsmed Inc For: 22 June By Investing.com - Investing.com Nigeria
CARL Q1 2026 Earnings: EPS Beats Estimates as Pre-Revenue Company Focuses on Personalized Spine ExpansionSpecial Dividend Alert - dars.gov.et
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CARL: AI-driven personalized surgery platform accelerates growth and efficiency, outpacing traditional models - TradingView
CARLSMED INC (CARL) Stock Chart - ChartMill
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
CARL Q1 2026 Earnings: Narrower-than-Expected Loss as Development Progress ContinuesPeak Earnings Alert - newsline.com
Carlsmed Shareholders Back Directors and Auditor at Meeting - TipRanks
Carlsmed Stock Faces A Crucial Week After Friday’s Drop - Bez Kabli
Carlsmed, Inc. Cash Flow – LSX:A41CM7 - TradingView
CARL Q1 2026 Earnings: Personal Surgery Specialist Beats EPS Estimates; Stock RisesEarnings Surprise Score - The Legal Advocate
CARLCarlsmed Inc Stock Price and Quote - Finviz
Wall Street analysts see a 51.94% upside in Carlsmed, Inc. (CARL): Can the stock really move this high? - MSN
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? - sharewise.com
Basic earnings per share (basic EPS) of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Carlsmed (CARL) Stock: Jumps +3.57%, Approaching $11.89 2026-05-19Free Signal Network - Newser
Carlsmed (CARL) Down -1.66% — How Low Could It Go? 2026-05-14Earnings Breakout - newser.com
Price to cash flow ratio of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Return on equity % of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Income Statement – LSX:A41CM7 - TradingView
Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for Aprevo lumbar - MSN
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Number of shareholders of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Carlsmed, Inc. Dividends – LS:A41CM7 - TradingView
Number of employees of Carlsmed, Inc. – LS:A41CM7 - TradingView
Operating expenses (excl. COGS) of Carlsmed, Inc. – LS:A41CM7 - TradingView
Enterprise value to EBITDA ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total debt per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Price to cash flow ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LS:A41CM7 - TradingView
3.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):